Prices keep rising for drugs treating painful sex in women

An analysis by GoodRx reveals that the price of creams, vaginal rings, and tablets containing estradiol, used to treat a dry vagina, have been increasing in recent years.

An analysis by GoodRx reveals that the price of creams, vaginal rings, and tablets containing estradiol, used to treat a dry vagina, have been increasing in recent years. While estradiol has been available for years, insurance coverage is limited, with some plans refusing to cover some products or mandating that patients pay high out-of-pocket costs. However, estradiol products may not attract much public outcry, in part because women's sex lives and their vaginas are still fairly taboo topics. According to GoodRx, the price of a tube of Estrace cream has risen from a pharmacy cash price of $183.98 in January 2013 to $372.17 in May of this year. Meanwhile, the Estring—which is inserted in the vagina for 3 months—cost $520.66 in May, compared with $284.11 in January 2013. FDA recently approved a new product, estradiol vaginal inserts (Imvexxy—TherapeuticsMD). The product's manufacturer said only that it would be sold at "parity" with others on the market. TherapeuticsMD notes that Imvexxy comes in a lower, 4 mcg dose and comes in the form of a pink soft gel capsule that is manually inserted, instead of using a disposable plastic applicator.